Sensus Healthcare Appoints Larry Biscotti to Board as Class I Director

What Happened
Sensus Healthcare, Inc. (SRTS) filed a Form 8‑K (filed Jan 12, 2026) reporting that on January 5, 2026 the Board appointed Larry Biscotti as a Class I director, with a term expiring at the Company’s 2028 annual meeting. The Board has determined Mr. Biscotti to be an independent director under NASDAQ Rule 5605(a)(2). A company press release announcing the appointment was issued on January 7, 2026 and is included as an exhibit to the 8‑K.

Key Details

• Appointment date: January 5, 2026; term ends at the 2028 annual meeting.
• Independence: Board determined Mr. Biscotti is independent per NASDAQ listing standards (Rule 5605(a)(2)).
• Compensation: He will receive the same pro‑rata pay given to other non‑employee directors.
• No related arrangements or material interests reported; committee assignments have not yet been determined.

Why It Matters
This is a board-level governance update — an independent director addition can affect board oversight and committee composition once assignments are made. The filing notes no related‑party transactions or special compensation, suggesting the appointment is a standard governance change with no immediate financial impact disclosed for investors. Investors tracking corporate governance or board composition may view this as routine but relevant company news.